Please provide your email address to receive an email when new articles are posted on . KOLOA, Hawaii — Ultra-widefield fluorescein angiography may enable more ...

Longer-term follow-up of a randomized trial confirmed that prophylactic anti-VEGF therapy with aflibercept (Eylea) slows progression of diabetic retinopathy but does not improve visual acuity better ...

Diabetic retinopathy is a complication of diabetes that affects vision. Nonproliferative diabetic retinopathy describes the earlier stages of the condition before it progresses into the final and most ...

A new machine learning model can predict how quickly diabetic retinopathy will progress in individual patients. Unexpectedly, the algorithm relies on information clinicians rarely consider in routine ...

Ultrawidefield and 7 field imaging determine diabetic retinopathy severity levels with good concordance. Researchers included 785 participants (mean age, 61 years; 47% women) with type 1 diabetes from ...

Non-proliferative diabetic retinopathy is the earliest stage of this diabetes complication. You may not have symptoms, and medical treatments may not be needed aside from diabetes management. As ...

Maria Grant, MD, along with her team at the UAB Heersink School of Medicine Department of Ophthalmology and Visual Sciences teamed up with researchers from the University of Florida College of ...

No, diabetes-related retinopathy is not reversible. But you can slow down progression or stop it from getting worse through diabetes management, eye injections, laser treatment, and more. Diabetic ...

Perimetry, also known as visual field testing, is an essential diagnostic tool for assessing various ophthalmic conditions, including glaucoma, optic neuropathies, and disorders affecting the retina ...

Diabetic retinopathy is an eye condition that can cause vision changes and vision loss. There are four stages of diabetic retinopathy based on the findings of a dilated eye exam. Diabetic retinopathy ...